ReviewAnnals of the rheumatic diseases2004

Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.

L H Calabrese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.